Enhabit prelim Q2 2024 adj. EBITDA $24.5-25.0M, reduces debt $15M, admissions up 6.4% YoY

Enhabit, Inc.

2024-Q2 EPS reported $0.00 revenue$523,000,000

Adjusted EBITDA guidance of $24.5M-$25.0M for Q2 2024.
Reduced bank debt by $15M, including $10M revolver payment.
Home health admissions up 6.4% year-over-year, driven by non-Medicare.
43% of non-Medicare visits in payor innovation contracts, up from 38% in Q1.
Hospice average daily census grew month-over-month for fifth straight month in June.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.